Brief: Viveve Medical Announces FDA Approval To Conduct Pursuit Trial For Improvement Of Stress Urinary Incontinence
July 7 (Reuters) - Viveve Medical Inc VIVE.O :
* VIVEVE MEDICAL INC ANNOUNCES FDA APPROVAL TO CONDUCT
PURSUIT
TRIAL FOR IMPROVEMENT OF STRESS URINARY INCONTINENCE
* VIVEVE MEDICAL INC - INITIATION OF PIVOTAL PURSUIT TRIAL
IS
TARGETED FOR Q4 2020 FOLLOWING PENDING RESULTS FROM COMPANY'S
SUI FEASIBILITY STUDY
Source: (https://bit.ly/2ACb9n7)
Further company coverage: VIVE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viveve Medical
See all newsU.S. STOCKS ON THE MOVE-Chord Energy, Kroger, PetMed Express
U.S. STOCKS ON THE MOVE-DoorDash, Walt Disney, Tesla
U.S. STOCKS ON THE MOVE-Papa John's, Whirlpool, Coca-Cola
Viveve Medical plunges as urinary disease drug fails to meet main goal
Brief: Viveve Medical Inc - Company Will Seek Strategic Alternatives And Will Be Delisted From Nasdaq